Metabolism - Clinical and Experimental
Volume 45, Issue 4 , Pages 469-474, April 1996

Obesity and high-density lipoprotein cholesterol in black and white 9- and 10-year-old girls: The National Heart, Lung, and Blood Institute Growth and Health Study

  • John A. Morrison

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA
  • ,
  • Dennis Sprecher

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA
  • ,
  • Robert P. McMahon

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA
  • ,
  • Joel Simon

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA
  • ,
  • George B. Schreiber

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA
  • ,
  • Philip R. Khoury

      Affiliations

    • Division of Cardiology, Children's Hospital Medical Center, CincinnatiUSA
    • Division of Lipid Research, Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, OHUSA
    • Maryland Medical Research Institute, Baltimore, MDUSA
    • General Internal Medical Section, Veterans Affairs Medical Center, and Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CAUSA
    • Westat, Inc, Rockville, MDUSA

Received 1 May 1995; accepted 9 September 1995.

Abstract 

It has been hypothesized that the role of obesity in the pathogenesis of coronary heart disease (CHD) may be mediated in part through its inverse relationship with high-density lipoprotein cholesterol (HDL-C). Obesity is inversely correlated with HDL-C, and HDL-C has been shown to be protective against CHD. Defining obesity as excess weight due to excess fat, the purpose of this analysis was to determine whether the effects of obesity are due to increased weight or to increased adiposity. Using baseline lipid and anthropometric data from the National Heart, Lung, and Blood Institute Growth and Health Study, cross-sectional associations among body mass, adiposity, HDL-C, and related lipid parameters (apolipoprotein [apo] Al and triglycerides [TGs]) were assessed in 821 white and 763 black 9- and 10-year-old girls, using multivariate linear regression models. Equations predicting HDL-C, apo Al, and TGs from age, race, sexual maturation stage, adiposity (sum of truncal—subscapular and suprailiac—skinfolds), and ponderosity (a ratio of weight to height) revealed that adiposity, not ponderosity, was the significant body composition variable to explain the variability of each of the lipids assessed. The amount of variance explained in each of the models was small (R2 ≤ .10). When apo Al and TGs were added to the HDL-C model, R2 increased to 0.44 and race differences were no longer significant. These findings suggest that adiposity, not ponderosity, explains the effects of obesity on HDL-C, the effects are mediated through apo Al and TGs, and that black-white differences in HDL-C are a result of apo Al— and TG-metabolic differences between the races.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by contracts no. N01-HC-55023-26 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

PII: S0026-0495(96)90221-8

Metabolism - Clinical and Experimental
Volume 45, Issue 4 , Pages 469-474, April 1996